SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series.

Autor: Gill SK; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada., Hernaiz-Leonardo JC; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Edens TJ; Devil's Staircase Consulting, West Vancouver, British Columbia, Canada., Pascual A; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Tang C; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada., Fan J; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Thamboo A; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Mullings W; Department of Surgery, University Hospital of the West Indies, Mona, Jamaica., Alsaleh S; Department of Otolaryngology-Head and Neck Surgery, King Saud University, Riyadh, Saudi Arabia., Alim BM; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.; Prince Mohammed Bin Abdulaziz Hospital, National Guard Health Affairs, Medina, Saudi Arabia., Javer AR; St. Paul's Sinus Centre, Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Manges AR; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Jazyk: angličtina
Zdroj: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2024 Aug; Vol. 14 (8), pp. 1386-1390. Date of Electronic Publication: 2024 Apr 14.
DOI: 10.1002/alr.23352
Abstrakt: Key Points: SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days. The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis. These promising SNMT results warrant further study of safety and efficacy.
(© 2024 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.)
Databáze: MEDLINE
Externí odkaz: